Cresco Labs Is A New Leader In U.S. Cannabis
Cresco Labs (OTCMKTS:CRLBF) is a Chicago, Illinois-based cannabis company and one that has long been on my radar. The company is fast-emerging as a leader in the U.S. as a multi-state, vertically integrated company. Over the course of the last year, it has worked hard to strengthen the balance sheet, increase sales, control costs, and continue growing and by all measures, it is getting the job done. What I want to bring to your attention today is that this cannabis company is turning a profit. The combined effects of organic growth, expanding production, and cost-controls produce a net profit for this company, unlike its Canadian peers, and this is only the beginning.
“Cresco Labs entered the third quarter firing on all cylinders achieving record levels of revenue, profitability, and cash flow. We remain the number one operator in the industry focused on, and delivering results in, the wholesale distribution of branded products. Our retail is outperforming, and we are generating substantial operating leverage,” said Charles Bachtell, Co-founder and CEO of Cresco Labs.
Cresco Labs Is Growing, Growing, Growing
Cresco Labs reported the kind of Q3 results the cannabis market has waited years to see. Starting at the top-line, revenue came in at $153.3 million or up 323% over the last year. Revenue growth is due to organic gains in all markets but one amplified by the addition of two new stores. On a QoQ basis, revenue grew 63% and is accelerating. On a wholesale basis, revenue is up 64.9% over the prior quarter while retail trails at a mere 60%. Wholesale revenue gains are driven by increased capacity, larger harvests, and the expansion into California. Retail sales gains are driven by strong sequential and YOY comps and new stores.
Moving down to the bottom line, the company reported positive EBITDA in the amount of $46.4 million. This is up 182% over the last quarter and driven by the combined effects of higher revenue and wider operating profit margins across the company’s footprint. The company was also able to leverage its expenses. SG&A costs held steady over the course of the quarter and fell as a percentage of revenue. More importantly, the net earnings came in at $4.9 million (more than zero) versus the -$4.7 million loss posted in the second quarter of the year.
Looking forward, the company is generating positive cash flow so should be able to sustain growth over the next year. The operating cash flow increased by 80% over the last quarter to top $17.5 million and is not expected to slow. The total cash is sitting near $57.7 million or up by $8.8 million versus the end of fiscal 2019. Cash flow is expected to increase as the company scales.
“The investments we made to support growth are paying off, and as a result our profitability has grown dollar for dollar with gross profit. Because of the decisions we’ve made, the changes we’ve managed through and the hard work devoted by our team over the last 12 months, Cresco Labs has substantiated itself within the very top tier of the industry and confirmed the value that is driven by our differentiated strategy,” continued Mr. Bachtell.
There Are Triple-Digit Gains In Store For Cresco Labs
The analysts are very bullish on this stock and I can understand why. There have been 7 notes issued this year, 2 recently, and they all see this stock trading well above its current levels. The consensus target is about 26% above the recent price action but that’s just the beginning. If the more recent calls are right this stock could easily double in price.
Looking at the chart, the trend is bullish and strong. There is a risk of some nearer-term weakness in price action because of a possible divergence in the MACD but that’s one of those signals that shouldn’t be relied on too heavily. The MACD is still on the rise and could set a new high in the coming weeks. If the price were to fall it would present a buying opportunity. The first targets for support are near $9.00, $8.50, and $8.00.
Companies Mentioned in This Article
Compare These Stocks
Add These Stocks to My Watchlist
7 Tech Stocks To Buy On Sale
This too shall pass. Those four words should be taped to the computer screen of every investor. If you own shares of the tech sector, you’ve seen your portfolio take quite a hit. Tech stocks were largely immune from the effects of the pandemic.
However, as investors are looking to rebalance their portfolios, tech stocks were obvious targets for some profit-taking. And at the end of the day, that’s what I believe the latest tech selloff amounts to. Stocks don’t move in one direction all the time. Sure, there may be some saber-rattling about breaking up big tech. But with an election in less than two months, nobody will have the political will to do anything.
That doesn’t mean that it’s all going to be smooth sailing. Sure, the Federal Reserve did its part by promising low-interest rates until the end of time (or at least through 2023 whatever comes first). But the rest of 2020 is likely to be volatile for stocks.
First, there’s still the novel coronavirus hanging around. It’s not going to simply disappear after election day. That will take some combination of a vaccine and/or therapeutic. And all the likely candidates seem to be getting farther away the deeper into clinical trials they get.
And we have an election. But we are not likely to know the winner of the election on election night. In fact, for those who remember the spectacle of “hanging chads”, this election could make that one look like amateur hour.
The bottom line is there will be uncertainty. But there are always gains to be found, particularly now that their stock price has come down a little bit. Here are seven tech stocks that you can look to add or increase a position in now that they’re trading at a discount.
View the "7 Tech Stocks To Buy On Sale".